[1]CurrentPatentAssignee:SCORPIONTHERAPEUTICS-WO2022/66734,2022,A1Locationinpatent:Page/Pagecolumn887-888
[2]CurrentPatentAssignee:SCORPIONTHERAPEUTICS-WO2022/66734,2022,A1Locationinpatent:Page/Pagecolumn887-888
1196151-53-7
72788-95-5
1270497-52-3
1049750-09-5 | 2-[1-(Cyclopropylmethyl)-2-piperazinyl]ethanol dihydrochloride | AA009MXD | MFCD08689407
1028126-98-8 | 2-((4-Fluorophenyl)sulfonyl)ethanamine hydrochloride | AA009OPH | MFCD08548471
1125-31-1 | 3-Methyl-1h-indol-4-ol | AA009QWX | MFCD05668010
111786-07-3 | Prinoxodan | AA009U23 | MFCD00867136
1347750-75-7 | t-Boc-N-amido-PEG3-acid | AA009VR9 | MFCD24539476
135311-97-6 | 6,7-Dihydroisoquinolin-8(5h)-one hydrochloride | AA009WGX | MFCD18432614
1415566-28-7 | 2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- | AA009WM3 | MFCD31654721
1355246-90-0 | Methyl 1-cyclopentylbenzimidazole-5-carboxylate | AA009WQ4 | MFCD21332962
1329399-10-1 | 3-Bromo-N-cyclopentyl-5-fluorobenzamide | AA009WTH | MFCD21369418
1262006-39-2 | 5-(4-Chloro-3-methylphenyl)-6-hydroxynicotinic acid | AA009WXR | MFCD18317651
1369243-54-8
706769-04-2
1798523-72-4
1358390-66-5